Case report of sacituzumab govitecan-hziy-induced neutropenia in a patient with metastatic triple-negative breast cancer and a uridine diphosphate glucuronosyltransferase family 1 member A1 poor metabolizer genotype

Baek, G; Jung, L; Duong, A; Gralow, J

Baek, G (通讯作者)，Seattle Canc Care Alliance, Dept Pharm, 1354 Aloha St, Seattle, WA 98109 USA.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022; 28 (3): 710

Abstract

Introduction Sacituzumab govitecan-hziy, approved in 2020 for treatment of metastatic triple-negative breast cancer, provides a new option for a popul......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索